STERIS plc (STE)
NYSE · Healthcare · Medical - Specialties
Profile
STERIS plc
- Exchange
- NYSE
- Ticker
- STE
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- US
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
Key facts
STERIS plc: key facts
- STERIS plc (NYSE: STE) is a Medical - Specialties company in the Healthcare sector.
- In fiscal 2026, STERIS plc reported revenue of $5.9B and net income of $785.1M.
- Revenue grew 8.9% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $6.0B and net income was $805.1M.
MonkScore
STERIS plc's MonkScore
MonkScore
MonkScore range: 40–50
as of October 2026
Sector rank: 393 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth30–40
- Profitability50–60
- Quality30–40
- Market Conviction40–50
- Safety30–40
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
STERIS plc's annual figures and the last twelve months, in USD. Last report: 30 June 2026.
| Figure | Last 12 months | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Revenue | $6.0B | $5.9B | $5.5B | $5.1B | $4.5B | $4.2B |
| Gross profit | $2.7B | $2.6B | $2.4B | $2.2B | $2.0B | $1.9B |
| Operating income | $1.1B | $1.1B | $866.6M | $836.1M | $791.1M | $477.8M |
| Net income | $805.1M | $785.1M | $614.6M | $378.2M | $107.0M | $243.9M |
| Operating cash flow | $1.3B | $1.3B | $1.1B | $973.3M | $756.9M | $684.8M |
| Capital expenditure | -$362.9M | -$369.0M | -$370.1M | -$360.3M | -$362.0M | -$287.6M |
| Free cash flow | $925.6M | $972.4M | $778.0M | $612.9M | $395.0M | $397.2M |
| Total debt | $2.0B | $2.1B | $2.2B | $3.4B | $3.2B | $3.3B |
| Cash | $482.3M | $439.6M | $171.7M | $207.0M | $208.4M | $348.3M |
Revenue growth a year
- 1-year
- 8.7%
- 3-year
- 9.4%
- 4-year
- 8.9%
Compound growth between fiscal years.
Peers
Similar companies
- 908 Devices Inc.NASDAQ:MASSMonkScore range: 40–50
- Mesa Laboratories, Inc.NASDAQ:MLABMonkScore range: 60–70
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.